Baker Nancy A, Vuong Diep, Bussell Mark, Gharibvand Lida, Lee Sarah, Tsao Bryan
Department of Neurology, Loma Linda University (LLU) School of Medicine, Loma Linda, California.
Department of Physical Medicine & Rehabilitation, Loma Linda University (LLU) School of Medicine, Loma Linda, California.
Arch Rehabil Res Clin Transl. 2022 Mar 29;4(2):100193. doi: 10.1016/j.arrct.2022.100193. eCollection 2022 Jun.
To perform a pilot study to assess the efficacy of intraneural facilitation, a novel manual technique, in the treatment of carpal tunnel syndrome (CTS).
Patients with clinical and electrodiagnostic evidence of CTS were randomized into intraneural facilitation or sham groups.
Electrodiagnostic laboratory in a university medical center.
Patients referred to our electrodiagnostic laboratory were screened based on nerve conduction studies that were diagnostic for distal median neuropathy at the wrist or CTS. A total of 14 participants were enrolled; 4 participants withdrew prior to randomization, with the remaining 10 participants (N=10) divided equally between treatment and control groups. There was a 9:1 female-to-male sex ratio and average duration of symptoms was 28.5 months.
Treatment was performed twice weekly for 3 weeks.
Primary outcomes were the Boston Carpel Tunnel Questionnaire (BCTQ) and Boston Functional Status Scale at enrollment and at 1 week and 3 months after completion of intervention. A secondary outcome was ultrasonography (US) of the median nerve performed at baseline and 1 week after intervention.
Ten participants completed the trial, 5 each in the treatment and 5 each in the sham groups. The total percentage change in BCTQ and Boston Functional Status Scale scores decreased at baseline, 1 week, and 3 months after intervention. However, there was no difference between control and intraneural facilitation group. Within-group differences showed nonstatistically significant differences for all the groups except for the BCTQ questionnaires after 3 months of intraneural facilitation therapy was completed (=.043) compared with baseline. Between-group differences showed large effects for the BCTQ questionnaires (=1.933) and wrist to forearm ratio (WFR) 1 week after completion of intervention.
This pilot study suggests that intraneural facilitation might improve symptoms and possibly function but did not improve median nerve cross-sectional area or WFR in CTS at follow-up evaluation 3 months after completion of intervention.
开展一项初步研究,以评估一种新型手法技术——神经内易化术治疗腕管综合征(CTS)的疗效。
将具有CTS临床和电诊断证据的患者随机分为神经内易化术组或假手术组。
大学医学中心的电诊断实验室。
转介至我们电诊断实验室的患者,根据诊断为腕部正中神经远端神经病变或CTS的神经传导研究进行筛选。共招募了14名参与者;4名参与者在随机分组前退出,其余10名参与者(N = 10)平均分为治疗组和对照组。男女比例为9:1,症状平均持续时间为28.5个月。
每周进行两次治疗,持续3周。
主要结局指标为入组时、干预结束后1周和3个月时的波士顿腕管问卷(BCTQ)和波士顿功能状态量表。次要结局指标为干预基线时和干预后1周时正中神经的超声检查(US)。
10名参与者完成了试验,治疗组和假手术组各5名。干预后基线、1周和3个月时,BCTQ和波士顿功能状态量表评分的总百分比变化均有所下降。然而,对照组和神经内易化术组之间没有差异。组内差异显示,除神经内易化术治疗3个月后与基线相比BCTQ问卷(P =.043)外,所有组的差异均无统计学意义。组间差异显示,干预结束后1周时BCTQ问卷(P = 1.933)和腕前臂比(WFR)有较大影响。
这项初步研究表明,神经内易化术可能改善症状并可能改善功能,但在干预完成3个月后的随访评估中,并未改善CTS患者的正中神经横截面积或WFR。